Nuclear Localization of Ataxin-3 Is Required for the Manifestation of Symptoms in SCA3:<i>In Vivo</i>Evidence
Ulrike Bichelmeier(University of Tübingen), Olaf Rieß(University of Tübingen), Thorsten Schmidt(University of Tübingen), Sven Poths(University of Tübingen), Werner Schmidt(Technische Hochschule Ingolstadt), Michael von Bonin(Urologische Klinik München), Lukas Rüttiger(University of Tübingen), Franco Laccone(Medical University of Vienna), Johannes Wilbertz(University of Basel), Marlies Knipper(University of Tübingen), Jeannette Hübener‐Schmid(Bernstein Center for Computational Neuroscience Tübingen), Karina Häbig(Medical Genetics Center), Hartwig Wolburg(University of Tübingen), Jana Boy(Medical Genetics Center)
Cited by 205
Related Papers
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis
|The Lancet Neurology|2004|1.1k
Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
|EMBO Reports|2006|1k
Vascular Endothelial Growth Factor Induces Endothelial Fenestrations In Vitro
|The Journal of Cell Biology|1998|649
14-3-3 proteins in the nervous system
|Nature reviews. Neuroscience|2003|625